Completed NA INTERVENTIONAL 1-arm NCT00939666

Minimal Invasive Strategies for Good and Complete Response to Chemoradiation in Rectal Cancer

Minimal Invasive Treatment for Patients With Good Response to Chemoradiation With Selection and Follow-up by MRI: a Single Arm Phase-II Feasibility Study in Rectal Cancer

Sponsor: Maastricht University Medical Center

Conditions Locally Advanced Rectal Cancer

Interventions Wait&see or TEM with intensive follow-up

Updated 6 times since 2017 Last updated: Mar 22, 2017 Started: Jul 1, 2009 Primary completion: Sep 1, 2014 Completion: Sep 1, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Locally Advanced Rectal Cancer and is currently completed. Maastricht University Medical Center leads this study, which shows 6 recorded versions since 2009 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Apr 2017 — Jun 2018 [monthly]

Completed NA

Status: Unknown Status → Completed · Phase: PHASE2 → NA

▶ Show 1 earlier version

Jan 2017 — Apr 2017 [monthly]

Unknown Status PHASE2

First recorded

Jul 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Maastricht University Medical Center

Data source: Maastricht University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Maastricht, Netherlands
• Roermond, Netherlands